07:00 , Sep 9, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Renal disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Renal disease Glomerulonephritis Complement factor H-related 5 (CFHR5) A genetic study in humans identified a mutation in CFHR5 that could be associated with glomerulonephritis. In...